Drug-drug Interaction Trial With Tralokinumab in Moderate to Severe Atopic Dermatitis - ECZTRA 4

NCT03556592 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Atopic Dermatitis

Interventions

DRUG: Tralokinumab
DRUG: Caffeine
DRUG: Warfarin
DRUG: Omeprazole
DRUG: Metoprolol
DRUG: Midazolam Hydrochloride

Sponsor

LEO Pharma